Key information relating to the proposed cash dividend by Entra ASA
Idag, 07:02
11.2.2026 07:02:00 CET | Entra ASA | Additional regulated information required to be disclosed under the laws of a member state
Dividend amount: NOK 1.10 per share (semi-annual dividend for H2 2025)*
Declared currency: NOK
Date of approval: 21 April 2026
Last day including right: 21 April 2026
Ex-date: 22 April 2026
Record date: 23 April 2026
Payment date: On or around 5 May 2026
* Subject to approval at the AGM on 21 April 2026.
This information is published in accordance with the requirements of the Continuing Obligations.
Disclosure regulation
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
Attachments
Ämnen i artikeln
Key information relating to the proposed cash dividend by Entra ASA
Idag, 07:02
11.2.2026 07:02:00 CET | Entra ASA | Additional regulated information required to be disclosed under the laws of a member state
Dividend amount: NOK 1.10 per share (semi-annual dividend for H2 2025)*
Declared currency: NOK
Date of approval: 21 April 2026
Last day including right: 21 April 2026
Ex-date: 22 April 2026
Record date: 23 April 2026
Payment date: On or around 5 May 2026
* Subject to approval at the AGM on 21 April 2026.
This information is published in accordance with the requirements of the Continuing Obligations.
Disclosure regulation
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
Attachments
Ämnen i artikeln
Rapporter
Analyser
Japan
Novo Nordisk
Mest läst
Rapporter
Analyser
Japan
Novo Nordisk
Marknadsöversikt
1 DAG %
Senast
1 mån
